These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 25792630)

  • 1. Towards tuberculosis elimination: an action framework for low-incidence countries.
    Lönnroth K; Migliori GB; Abubakar I; D'Ambrosio L; de Vries G; Diel R; Douglas P; Falzon D; Gaudreau MA; Goletti D; González Ochoa ER; LoBue P; Matteelli A; Njoo H; Solovic I; Story A; Tayeb T; van der Werf MJ; Weil D; Zellweger JP; Abdel Aziz M; Al Lawati MR; Aliberti S; Arrazola de Oñate W; Barreira D; Bhatia V; Blasi F; Bloom A; Bruchfeld J; Castelli F; Centis R; Chemtob D; Cirillo DM; Colorado A; Dadu A; Dahle UR; De Paoli L; Dias HM; Duarte R; Fattorini L; Gaga M; Getahun H; Glaziou P; Goguadze L; Del Granado M; Haas W; Järvinen A; Kwon GY; Mosca D; Nahid P; Nishikiori N; Noguer I; O'Donnell J; Pace-Asciak A; Pompa MG; Popescu GG; Robalo Cordeiro C; Rønning K; Ruhwald M; Sculier JP; Simunović A; Smith-Palmer A; Sotgiu G; Sulis G; Torres-Duque CA; Umeki K; Uplekar M; van Weezenbeek C; Vasankari T; Vitillo RJ; Voniatis C; Wanlin M; Raviglione MC
    Eur Respir J; 2015 Apr; 45(4):928-52. PubMed ID: 25792630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards elimination of tuberculosis in New Zealand.
    Verrall AJ; Hill PC; Thorburn D; Maze M; Perumal L; Grimwade K; Thornley CN; Freeman J; Nisbet M; Blackmore TK
    N Z Med J; 2020 Apr; 133(1513):89-96. PubMed ID: 32325472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress Toward Tuberculosis Elimination and Tuberculosis Program Performance - National Tuberculosis Indicators Project, 2016-2022.
    Woodruff R; Pratt R; Kolasa M
    MMWR Surveill Summ; 2024 Jun; 73(4):1-18. PubMed ID: 38833409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tuberculosis in Asia].
    Kekkaku; 2002 Oct; 77(10):693-7. PubMed ID: 12440145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cameroon's MDR-TB treatment programme jeopardised by cross-border migration.
    Noeske J; Foe JL; Kuaban C
    Eur Respir J; 2016 Feb; 47(2):684-6. PubMed ID: 26828058
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of tuberculosis and multidrug resistant tuberculosis in the Middle East Region.
    Ahmad S; Mokaddas E; Al-Mutairi NM
    Expert Rev Anti Infect Ther; 2018 Sep; 16(9):709-721. PubMed ID: 30173588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis problems in the Asia-Pacific region.
    Shimouchi A
    Respirology; 2001 Mar; 6(1):75-8. PubMed ID: 11264768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
    Fears R; Kaufmann S; Ter Meulen V; Zumla A;
    Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration.
    Matteelli A; Lönnroth K; Mosca D; Getahun H; Centis R; D'Ambrosio L; Jaramillo E; Migliori GB; Raviglione MC
    Eur Respir J; 2016 Feb; 47(2):686-8. PubMed ID: 26828059
    [No Abstract]   [Full Text] [Related]  

  • 12. What will it take to eliminate drug-resistant tuberculosis?
    Kendall EA; Sahu S; Pai M; Fox GJ; Varaine F; Cox H; Cegielski JP; Mabote L; Vassall A; Dowdy DW
    Int J Tuberc Lung Dis; 2019 May; 23(5):535-546. PubMed ID: 31097060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis-a World Health Organization Perspective.
    Sotgiu G; Sulis G; Matteelli A
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points.
    Lönnroth K; Mor Z; Erkens C; Bruchfeld J; Nathavitharana RR; van der Werf MJ; Lange C
    Int J Tuberc Lung Dis; 2017 Jun; 21(6):624-637. PubMed ID: 28482956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis: a new vision for the 21st century.
    Small PM
    Kekkaku; 2009 Nov; 84(11):721-6. PubMed ID: 19999594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerating tuberculosis elimination in low-incidence settings: the role of genomics.
    Sotgiu G; Cirillo DM; Miotto P; Centis R; Migliori GB
    Eur Respir J; 2015 Dec; 46(6):1841-3. PubMed ID: 26621890
    [No Abstract]   [Full Text] [Related]  

  • 18. Accelerating tuberculosis elimination in low-incidence settings: the role of genomics.
    Guthrie JL; Gardy JL
    Eur Respir J; 2015 Dec; 46(6):1840-1. PubMed ID: 26621889
    [No Abstract]   [Full Text] [Related]  

  • 19. The Global TB Drug Facility: innovative global procurement.
    Kumaresan J; Smith I; Arnold V; Evans P
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):130-8. PubMed ID: 14974756
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 37.